LFR a bacterium (MRSA, yellow) being ingested by an immune cell (Neutrophil, purple)LFR lung cancer cell during cell divisionMoores Cancer Center


NCI logoOne revolutionary building brings together research, education, and clinical care where our clinicians and scientists advance patient care through translational research. As an NCI-designated comprehensive cancer center, Moores Cancer Center is at the forefront of the fight against cancer. From research in molecular genetics to the most advanced clinical treatments, we are developing promising new therapies and making them available to cancer patients throughout the region. Read More >

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor. In a report, published online in Nature Medicine  on April 22, 2019, University of California San Diego School of Medicine researchers found that treating patients with personalized, combination therapies improved outcomes in patients with therapy resistant cancers. Read more in the press release